Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BK Giulini is a prominent specialty chemical company and a subsidiary of the ICL Group, specializing in high-quality ingredients for the pharmaceutical, food, and industrial sectors. In the life sciences arena, the company is a leading manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs), with a particular focus on inorganic salts used in antacids and as tablet binders. Their product portfolio includes essential components for oral solid dosage forms, such as calcium phosphates and magnesium salts, produced under strict GMP standards. Headquartered in Ludwigshafen, Germany, BK Giulini leverages over a century of expertise in phosphate chemistry to provide technical solutions for drug formulation and stability. The company serves as a critical supplier to global pharmaceutical manufacturers, supporting the development of both over-the-counter and prescription medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BK Giulini.